ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Summary of Key Concepts"
Episode Synopsis
Subcutaneous ICI products may offer significant time savings for patients, caregivers, and health care facilities with shorter compounding, administration, and chair timeWith multiple ICI therapies now approved for subcutaneous injection and more under development, it is vital for institutions to develop interprofessional/multidisciplinary approaches and workflows to integrate novel therapies
More episodes of the podcast Conversations With Cancer Experts About Novel Delivery Options With Checkpoint Inhibitors (ICIs)
Background of ICI & Highlights in Oncology
30/07/2025
In God we trust